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ABSTRACT  
Objective: The objective of this selective EBM review is to determine whether or not 
hydrotherapy improves health-related quality of life (HR-QoL) in adult men and women with 
multiple sclerosis (MS). 
Study Design: Review of three randomized controlled trials (RCTs) published between 2012-
current, all in the English language.  
Data Sources: Three randomized controlled trials (RCTs), all of which evaluate the 
effectiveness of hydrotherapy compared to a control group that was asked either not to change 
their exercise habits or to participate in land-based activities. All studies were found using 
PubMed and Embase.  
Outcomes Measured: Each of the three articles analyzed the effects of hydrotherapy on 
improving health-related quality of life. The Short form-36 (SF-36), Multiple Sclerosis Quality 
of Life-54 (MSQOL-54), and Multiple Sclerosis Impact Scale-29 (MSIS-29) were the 
questionnaires used to measure HR-QoL.  
Results: The studies by Castro-Sanchez et al.7 and Kargarfard et al.5 found that hydrotherapy 
significantly improved HR-QoL in adult MS patients compared to the control group. The study 
by Bansi et al.8 was inconclusive because HR-QoL improved both in the experimental and 
control group, with no significant difference between the two.  
Conclusions: Hydrotherapy was shown to improve HR-QoL in all three studies. However, in 
one study, HR-QoL improved independent of the therapy used, with no significant difference 
between the hydrotherapy and land-based exercise groups.8 Therefore, evidence is inconclusive.  
Keywords: Multiple Sclerosis, Hydrotherapy 
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INTRODUCTION 
Multiple sclerosis is an immune-mediated relapsing-remitting or progressive 
demyelinating disease of the CNS characterized by chronic inflammation, gliosis, and neuronal 
loss.1 The exact cause of MS is unknown. Risk factors include vitamin D deficiency, exposure to 
Epstein-Barr virus after early childhood, and cigarette smoking.1 Symptoms vary greatly from 
person to person and can range from asymptomatic to severe disease. Characteristic symptoms 
include exercise-induced weakness, optic neuritis, and heat sensitivity. Other common symptoms 
include spasticity, diplopia, paresthesias, ataxia, bladder dysfunction, depression, and fatigue.  
There are approximately 2.3 million individuals worldwide and 350,000 people in the 
United States with MS1, but there has not been a scientific, national study of prevalence since 
1975.2 Hospital admissions for MS are increasing, with the most recent data showing 102,473 ± 
3,485 in 2001, rising to 144, 716 ± 3,902 admissions in 2010.3 Total costs for all people with MS 
in the U.S. is approximately $28 billion annually.4 Annual costs, including both direct and 
indirect costs for a patient with MS in the U.S. is approximately $69,000.4 Approximately 
$39,000 consists of health care costs.4 
There is no cure for MS, only medications and other therapies to control symptoms, 
prevent exacerbations and slow the progression of the disease. Therefore, different forms of 
complementary and alternative medicine (CAM) are important considerations to reduce 
symptoms and improve daily functioning for MS patients. The mainstay of treatment for acute 
attacks is glucocorticoids. Plasma exchange can be used if the patient is refractory to steroids. 
Maintenance treatment can be achieved with disease-modifying agents that are injectable 
medications, such as IFN-β-1a (Avonex) and IFN-β-1a (Rebif); oral medications, such as 
fingolimod (Gilenya) and teriflunomide (Aubagio); or infused medications, such as mitoxantrone 
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(Novantrone) and alemtuzumab (Lemtrada).1 Aside from medications, comprehensive care of 
MS includes PT/OT, cognitive rehabilitation, vocational rehabilitation, and speech-language 
pathology. The goal of these treatment modalities is to improve and maintain function and to 
increase the quality of life for MS patients.  
With no definitive cure for MS, additional treatment modalities, including hydrotherapy, 
are being researched to determine their efficacy in improving the symptoms of MS. 
Hydrotherapy, also known as water therapy, aquatic therapy, pool therapy, and balneotherapy, is 
a type of alternative medicine that uses water in various ways to provide therapeutic effects. It is 
thought that the cooling effect of the water may help MS patients since the neurological 
symptoms associated with MS can be produced by an elevation in the body’s core temperature.1  
The potential benefits from hydrotherapy are based on the ideas that the pool water can reduce 
the body temperature and increase exercise tolerance compared to land-based exercise.5 It is also 
thought that the buoyancy of the water can decrease resistance against the body, allowing 
patients to endure longer periods of physical activity with less resulting fatigue.5 A study in 2011 
has found that walking is the most common type of physical activity reported by patients with 
MS, followed by gardening and weight training.6 Hydrotherapy may be a new promising 
recommendation by health care providers over traditional land-based exercises if the research 
supports its use. This paper evaluates three randomized controlled trials analyzing the effects of 
hydrotherapy as an adjunctive treatment for men and women with multiple sclerosis. 
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not hydrotherapy  
improves health-related quality of life (HR-QoL) in adult men and women with multiple  
sclerosis (MS). 
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METHODS 
The criteria used for the selection of the three RCT studies in this systematic review was 
based on the population demographics, interventions utilized, and the outcomes measured. The 
populations studied in these RCTs were men and women over the age of 18 with a formal 
diagnosis of multiple sclerosis. The intervention being studied is hydrotherapy. The control 
groups in two of the studies consisted of land-based exercises, including a land cycle ergometer 
and abdominal breathing combined with contraction-relaxation exercises. The third study 
utilized a control group that did not have any additional exercise requirements and were asked to 
make no changes to their normal routine. Health-related quality of life (HR-QoL) is the outcome 
being measured by these studies using patient-oriented evidence.  
Research for this systematic review was collected using Pubmed and Embase to find 
randomized controlled trials in peer-reviewed journals that were published no earlier than 2006. 
All three articles were published in the English language. Articles were selected based on their 
relevance to the objective of this systematic review and if outcomes measured were POEMs 
(patient-oriented evidence that matters). The keywords used to search for relevant articles were 
“multiple sclerosis” and “hydrotherapy”. The inclusion criteria for this systematic review 
required that patients were men and women over the age of 18. Anyone under the age of 18 and 
anyone who recently relapsed were excluded. Refer to Table 1 for inclusion and exclusion 
criteria specific to each of the three studies. These studies analyzed data using t-tests and 
ANOVA. Values reported were mean change from baseline, p-values, and confidence intervals.  
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Table 1 - Demographics & Characteristics of included studies 
Study Type #Pts Age 
(yrs) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/
D 
Interventions 
Bansi8 
(2013) 
Randomized 
Controlled 
Trial 
60 46-56 
years 
old 
Patients with 
MS diagnosis 
with EDSS 
between 1.0-
6.5  
Patients were 
excluded if 
incontinence, 
persistent 
infections, 
cardiovascula
r and 
pulmonary 
diseases, or if 
immunosuppr
essive 
therapy was 
existent. 
8 Daily 30 
minute 
endurance 
training on an 
aquatic bike 
x3 weeks 
 
Castro-
Sanchez
7 (2012) 
Randomized 
Controlled 
Trial 
73 18-75 
years 
old 
Patients 18-
75 years old 
with MS 
diagnosis 
who have 
VAS pain 
score > 4 for 
at least 2 
months and 
EDSS ≤ 7.5 
Treatment 
with another 
CAM 
(complementa
ry & 
alternative 
medicine) 
currently or 
within past 3 
months, 
relapse or 
steroid 
treatment 
within the 
past 2 months  
2 Twice-weekly 
20-week Ai-
Chi aquatic 
exercise 
program 
 
Kargarfa
rd5 
(2012) 
Randomized 
Controlled 
Trial 
32 Avg 
age = 
32.6 
Women with 
diagnosis of 
MS for ≥ 2 
years, no 
relapse 
within the 4 
weeks prior, 
ability to 
participate, 
EDSS ≤ 3.5 
 
Relapse 
during 
intervention 
period, 
comorbidities 
(cardiovascul
ar, 
pulmonary, 
skeletal 
disease) 
11 60 minute 
aquatic 
exercise 
program three 
times per 
week x8 
weeks 
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OUTCOMES MEASURED 
The outcome measured in these studies was health-related quality of life (HR-QoL), 
which looks at physical, mental, emotional and social functioning, focusing on how quality of 
life is impacted by health status. Castro-Sanchez et al. assessed HR-QoL using the MSIS-29 
scale.7 This scale measures HR-QoL using a 29-item self-report measure associated with a 
physical and psychological scale that questions patients about the impact MS has on their day-to-
day lives. Kargarfard et al. assessed HR-QoL using the Multiple Sclerosis Quality of Life-54 
(MSQOL-54), which consists of 54 items that are designed to measure composite scores for 
physical and mental health.5 Composite scores are determined using subscales, which assess 
physical function, physical and emotional role limitation, pain, emotional well-being, energy, 
health perceptions, social function, cognitive function, health distress, overall quality of life, and 
sexual function.5 Higher scores indicate better HR-QoL. Bansi et al. used the Short Form-36 (SF-
36) to assess HR-QoL, which looks at physical, mental and social aspects of health and how they 
impact quality of life for MS patients.8 
RESULTS 
 Three randomized controlled trials were used to determine if hydrotherapy served as an 
effective treatment to improve HR-QoL in MS patients over the age of 18. Data from these 
studies were continuous data and could not be converted to dichotomous form. Therefore, results 
evaluating treatment efficacy could not be calculated. 
Castro-Sanchez et al.7 followed 73 patients, with 36 patients in the experimental group 
(26 females) and 37 patients in the control group (24 females). Two patients in the control group 
were excluded due to relapse. Power calculations were performed, estimating a minimal sample 
size of 33 participants per group for a power of 80% and standard deviation (SD) of 3.1. There 
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was no significant difference in demographic characteristics between the groups. The 
intervention for the experimental group was an Ai-Chi exercise program conducted in a 
swimming pool with a water temperature of 36 °C. Exercises included a combination of deep 
breathing and broad movements of the arms, legs, and torso to work on strength, balance, 
flexibility, relaxation, and breathing. Tai-Chi music was also played during the sessions, which 
lasted 60 minutes each. The intervention for the control group consisted of exercise sessions that 
were conducted on land in a therapy room with a temperature of 26 °C. The patients underwent 
the same exercise program as the experimental group. No music was played during these 
sessions. The sessions were led by the same physiotherapist for the experimental and control 
groups. Both groups received treatment twice a week for 20 weeks. There was follow-up at 
weeks 24 and 30. For the purpose of this systematic review, focus will be on effects immediately 
post-treatment at 20 weeks. HR-QoL was measured using two scales. Using the MSIS-29 
Physical scale, there was a significant improvement in HR-QoL in the experimental group at 
week 20 (P < 0.013) that was also maintained at follow-up at weeks 24 (P<0.017) and 30 
(P<0.025). The control group showed no significant difference in HR-QoL at any time point 
during the study. As shown in Table 3, there were significant differences between the 
experimental and control groups at week 20 (P<0.014), as well as at follow-up at week 24 
(P<0.019) and week 30 (P<0.027). Using the MSIS-29 Psychological scale, both the 
experimental and control group showed a significant improvement in HR-QoL at week 20 (P < 
0.009 and P<0.046, respectively) that was maintained at the week 24 and week 30 follow-up. 
There were significant differences between the experimental and control group at week 20 
(P<0.023), as well as at week 24 follow-up (P<0.027) and week 30 follow-up (P<0.038), as  
shown in Table 3. This data demonstrates effects on HR-QoL that were superior in the  
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experimental group compared to the control group.7 
Table 2. Median and standard deviation values at baseline and week 20 with associated p-values 
 MSIS-29 Physical MSIS-29 Psychological 
Experimental Control Experimental Control 
Week 0 Median = 48 
St. dev = 15.91 
Median = 46 
St. dev = 18.34 
Median = 34 
St. dev = 29.47 
Median = 30 
St. dev = 23.53 
Week 20 Median = 41 
St. dev = 12.37 
Median = 45 
St. dev = 17.14 
Median = 21 
St. dev = 15.73 
Median = 25 
St. dev = 19.36 
% change 
from baseline 
78% 
improvement 
6%  
improvement 
81% 
improvement 
37% 
improvement 
p-value P<0.013 P<0.05 P <0.009 P <0.046 
 
Table 3. Median (SD) MSIS-29 scores, Comparing experimental and control groups at week 20 
 
Group 
 
Median (St. deviation) P-value 
MSIS-29 Physical 
Experimental 41 (12.37)  
P<0.014 
Control 45 (17.14) 
MSIS-29 Psychological 
Experimental 21 (15.73)  
P<0.023 
Control 25 (19.36) 
 
Kargarfard et al.5 recruited 32 women with relapsing-remitting MS into their study. Six 
patients from the exercise group and five patients from the control group were excluded from 
analysis due to relapse, personal circumstances, being unable to regularly participate in exercise 
training, or refusing to participate in measurement of outcomes at both 4 and 8 weeks. A 
sensitivity analysis was performed, which showed that the results of statistical significance were 
the same whether ITT or complete data were employed. Therefore, the results presented here are 
based on 21 patients, with 10 from the experimental group and 11 from the control group. There 
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was no significant difference in demographic characteristics between the groups. The 
intervention for the experimental group was a 60-minute aquatic exercise program three times 
per week for 8 weeks. The aquatic exercise took place in a swimming pool at a temperature 
maintained between 28-30°C. Exercises included those that focused on joint mobility, muscle 
strength, balance and posture, along with functional activities and intermittent walking. The 
control group was asked to maintain their current treatment and behavior over the 8 weeks. The 
Multiple Sclerosis Quality of Life-54 (MSQOL-54) scale was used to assess HR-QoL using two 
subscales, MSQOL-54-physical and MSQOL-54-mental. For MSQOL-54-physical and 
MSQOL-54-mental, the control group showed no significant difference from baseline to week 8. 
The experimental group did show a statistically significant difference in HR-QoL from baseline 
to week 8 for MSQOL-54-physical (P<0.001) and MSQOL-54-mental (P<0.001). Refer to Table 
4 for intragroup statistics and P values. Additionally, MSQOL-54-physical and MSQOL-54-
mental scores were significantly different between the experimental and control groups at week 8 
to the favor of the experimental group. Refer to Table 5 for intergroup statistics and P-values.5 
 
Table 4. Pairwise comparisons examining quality of life at baseline and 8 weeks with data 
expressed as mean differences ± SE 
 
 MSQOL-54-Physical MSQOL-54-Mental 
Experimental Control Experimental Control 
Difference 
between 
baseline and 8 
weeks 
 
 
21.5 ± 1.7 
 
 
 
0.7 ± 1.0 
 
25.8 ± 3.1 
 
1.1 ± 1.6 
p-value P<0.001 P>0.05 P <0.001 P >0.05 
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Table 5. Comparison of quality of life between experimental and control groups at week 8 
Group 
 
Mean ± SD P-value 
MSQOL-54-Physical 
Experimental 65.4 ± 6.6  
P<0.001 
Control 44.2 ± 4.4 
MSQOL-54-Mental 
Experimental 70.2 ± 5.7  
P<0.001 
Control 43.6 ± 8.9 
 
Bansi et al.8 followed 52 patients, with 24 patients in the experimental group and 28 
patients in the control group. Sixty patients were initially included in the study, but eight had 
been excluded due to immunosuppressive therapy being given during the study or inability to 
comply with the daily schedule of activities. There was no significant difference in demographic 
characteristics between the groups. The intervention for the experimental group was daily 30-
minute endurance training sessions on an aquatic bike for 3 weeks. Water temperature was held 
constant at 28 °C. The control group participated in daily 30-minute endurance training sessions 
on land cycle ergometers for 3 weeks. The Short form-36 (SF-36) was used to assess HR-QoL in 
this study. Both the experimental and control groups showed a statistically significant difference 
in SF-36 scores over the 3 weeks, as shown in Table 6. SF-36 scores did not show statistically 
significant group differences over the 3 week training period. There were beneficial effects on 
HR-QoL independent of the training setting. Refer to Table 6 for P-values.8 
Table 6. Time and group effects for the experimental and control group over 3 weeks 
 
 
SF-36 Total 
Score 
Time point 
Mean (95% CI) 
ANOVA p values 
t1 t2 Difference t2 – t1 Time Group 
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Experimental 
Group 
59.3 (50.8-68.2) 63.4 (55.7-71.7) 4.2 (-9.2 to 0.8) 0.031  
0.766 
Control 
Group 
53.9 (46.3-61.4) 58.4 (50.1-66.5) 4.46 (-9.3 to 0.4) 0.031 
 
 No adverse events related to the interventions utilized in these studies were reported. In 
the study by Kargarfard et al.5, lifeguards and pool safety equipment were available at all times. 
Also, patients were allowed to use a noodle or foam hand bars while performing exercises in this 
study.5 Hydrotherapy is a safe intervention with no obvious adverse effects related to its use. 
 
DISCUSSION  
 This systematic review explored the efficacy of hydrotherapy as an adjunctive treatment 
for patients with MS to improve health-related quality of life. The studies by Castro-Sanchez et 
al.7 and Kargarfard et al.5 showed significant improvements in HR-QoL, with no adverse effects 
noted. The third study by Bansi et al.8 showed improvement in HR-QoL independent of the type 
of exercise therapy.  
There were several limitations to these studies. In the study by Castro-Sanchez et al.7, the 
hydrotherapy group had the addition of ambient music during their training sessions, while the 
control group had no ambient music played during their land-based exercise training sessions. 
The contributions of this factor should be further explored. For the same study, it could not be 
guaranteed that participants were blinded to the nature of their group since they all belonged to 
the same organization. Generally speaking, there is a need for studies with larger sample sizes; 
the largest sample size in a study utilized in this systematic review was 71. Lastly, the time factor 
varied among the studies, with the effects of hydrotherapy measured from a range of 3 weeks – 
30 weeks. It would be beneficial to measure effects of the therapy over a longer duration of time.  
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Hydrotherapy does have limitations to its use. The cost could be a deterrent to patients 
who are on a budget. Insurance coverage for hydrotherapy varies, and paying out of pocket could 
easily add up over time. Some insurance companies, such as BlueCross BlueShield, require 
hydrotherapy to be administered by a certified physical therapist. Various insurance plans will 
not cover group exercise programs, but rather one on one sessions with a licensed provider. 
Additionally, only a certain number of sessions may be covered, which could lead to cessation of 
therapy before full effects of the treatment have been achieved. 
No contraindications were defined in the research regarding the use of hydrotherapy. 
CONCLUSIONS 
 Based on the current research available, the evidence is inconclusive on whether 
hydrotherapy improves HR-QoL in adult men and women with MS. Two out of the three studies 
show significant improvement in HR-QoL using hydrotherapy compared to the control group.5,7 
While the third study showed improvement in HR-QoL in both the group receiving hydrotherapy 
and the control group, there was no statistically significant difference between the two groups.8 
With this in mind, MS requires a multidisciplinary approach. With no notable adverse effects, 
hydrotherapy can be considered a safe alternative to traditional land-based exercise.  
There has been limited research on this topic, and further studies are warranted. With 
hydrotherapy being a broad term, the actual exercise regimens used varied greatly from study to 
study. In the two studies that showed improvement in HR-QoL, hydrotherapy consisted of 
exercises defined by various movements performed while standing in the water. The study that 
had inconclusive evidence to the benefits of hydrotherapy utilized an underwater bike for 
training sessions. It could be beneficial for future studies to focus on a more standardized 
exercise routine to have a more exact definition across the board of what hydrotherapy entails. 
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